| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 192 |
| 1 | ADALIMUMAB-ADAZ | 123 |
| 2 | ADALIMUMAB-AATY | 118 |
| 3 | ADALIMUMAB-FKJP | 117 |
| 4 | VEDOLIZUMAB | 97 |
| 5 | AZATHIOPRINE | 96 |
| 6 | PREDNISONE | 85 |
| 7 | USTEKINUMAB | 82 |
| 8 | METHOTREXATE SODIUM | 80 |
| 9 | INFLIXIMAB | 73 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | USTEKINUMAB-AUUB | 1 | 0.0057 |
| 1 | SODIUM PICOSULFATE, MAGNESIUM OXIDE, AND ANHYDROUS CITRIC ACID | 3 | 0.0041 |
| 2 | FIDAXOMICIN | 8 | 0.0033 |
| 3 | ADALIMUMAB-FKJP | 117 | 0.0025 |
| 4 | FOSNETUPITANT AND PALONOSETRON | 3 | 0.0025 |
| 5 | NETUPITANT AND PALONOSETRON | 3 | 0.0025 |
| 6 | ADALIMUMAB-AATY | 118 | 0.0024 |
| 7 | CARBAMIDE PEROXIDE | 1 | 0.0023 |
| 8 | ADALIMUMAB-ADAZ | 123 | 0.0022 |
| 9 | CLEMASTINE FUMARATE | 3 | 0.0022 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 199 |
| 1 | Corticosteroid [EPC] | 186 |
| 2 | Interleukin-23 Antagonist [EPC] | 123 |
| 3 | Integrin Receptor Antagonist [EPC] | 97 |
| 4 | Nucleoside Metabolic Inhibitor [EPC] | 97 |
| 5 | Purine Antimetabolite [EPC] | 96 |
| 6 | Interleukin-12 Antagonist [EPC] | 83 |
| 7 | Folate Analog Metabolic Inhibitor [EPC] | 59 |
| 8 | Aminosalicylate [EPC] | 56 |
| 9 | Nonsteroidal Anti-inflammatory Drug [EPC] | 38 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Macrolide Antibacterial [EPC] | 8 | 0.0079 |
| 1 | Medium-chain Triglyceride [EPC] | 1 | 0.0018 |
| 2 | Interleukin-23 Antagonist [EPC] | 123 | 0.0012 |
| 3 | Bile Acid Sequestrant [EPC] | 14 | 0.0011 |
| 4 | Integrin Receptor Antagonist [EPC] | 97 | 0.0011 |
| 5 | Endoglycosidase [EPC] | 2 | 0.0011 |
| 6 | Purine Antimetabolite [EPC] | 96 | 0.0010 |
| 7 | Vitamin K [EPC] | 8 | 0.0009 |
| 8 | Somatostatin Analog [EPC] | 6 | 0.0009 |
| 9 | Anti-coagulant [EPC] | 3 | 0.0008 |